OR WAIT 15 SECS
BioSC Lab is the first in a line of next-generation chromatography equipment for protein purification in batch and continuous modes.
Novasep, a supplier of manufacturing solutions for the life science industry, has launched BioSC Lab, the next-generation low-pressure chromatography equipment for the biopharmaceutical industry. Scientists will be able to purify a few grams of proteins per day either in continuous, batch, or even parallel batch modes with BioSC Lab.
According to Novasep, the simulation software BioSC Predict frees the process developer to set the most efficient mode and parameters to purify biomolecules such as monoclonal antibodies (mAbs), blood factors, and other proteins.
“Scientists are now asking for solutions to turn their traditional batch chromatography processes into continuous ones as early as the R&D stage,” said Jean-Luc Beulay, global product development director of Novasep’s Biopharma Business Unit, in a press statement. BioSC Lab has been designed to support this switch.
“BioSC Lab has all those features state-of-the-art chromatography equipment must have in terms of reliability and efficiency. What makes it unique is its flexibility in process operating modes. It is specifically designed to quickly provide the operator with the best operating parameters for purifying and converting a batch biochromatography method into a continuous, optimized one.”
BioSC Lab is the first in a line of next-generation chromatography equipment that Novasep will introduce to the market over the next few years.